Cardiovascular Pharmacotherapy


@Cardiovascular_Pharmacotherapy

Latest publications


Cardiovascular Pharmacotherapy
Publication date: 01 Jan, 10:02

Cardiogenic Shock NEJM review, 2026
👁 875 🔁 35
Cardiovascular Pharmacotherapy
Publication date: 24 Dec, 18:35

Media file
Antithrombotic Medications and Reversal Agents
👁 1313 🔁 9
Cardiovascular Pharmacotherapy
Publication date: 24 Dec, 18:34

Media file
Scheme evaluation of patients with TBI along with recommendation for reversal of antithrombotic medications, if indicated
👁 1272 🔁 7
Cardiovascular Pharmacotherapy
Publication date: 24 Dec, 17:12

Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists
👁 2100 🔁 30
Cardiovascular Pharmacotherapy
Publication date: 24 Dec, 17:12

Media file
Management of glucagon-like peptide-1 receptor agonist (GLP-1 RA)-induced gastrointestinal side effects
👁 1863 🔁 14
Cardiovascular Pharmacotherapy
Publication date: 24 Dec, 17:11

Media file
Role of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) across the Universal Definition of Heart Failure stages
👁 1655 🔁 8
Cardiovascular Pharmacotherapy
Publication date: 24 Dec, 17:11

Media file
Practical use of glucagon-like peptide-1 receptor agonists in patients with heart failure.
👁 1582 🔁 10
Cardiovascular Pharmacotherapy
Publication date: 19 Dec, 08:18

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document
👁 1388 🔁 31
Cardiovascular Pharmacotherapy
Publication date: 19 Dec, 08:17

Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton’s Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance
👁 1286 🔁 18
Cardiovascular Pharmacotherapy
Publication date: 10 Nov, 10:14

Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk (CORE2 TIMI 72)
👁 2201 🔁 12